Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1241-1250 of 2916 for cancer

Edit search filters
  1. Phase 3 Frontline Therapy Trial In Patients With Advanced Classical Hodgkin Lymphoma

    Rochester, MN

  2. A Study To Evaluate Triapine Combined With Lutetium Lu 177 Dotatate For Gastroenteropancreatic Neuroendocrine Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Wild-Type Reovirus In Combination With Sargramostim In Treating Younger Patients With High-Grade Relapsed Or Refractory Brain Tumors

    Rochester, MN

  4. Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Rochester, MN

  5. Study Of Tirabrutinib (ONO-4059) In Patients With Primary Central Nervous System Lymphoma (PROSPECT Study)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study Of MCLA-128 In Patients With Solid Tumors Harboring An NRG1 Fusion

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study Of SAR442085 In Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

  8. Nivolumab And Brentuximab Vedotin In Treating Older Patients With Untreated Hodgkin Lymphoma

    Rochester, MN

  9. A Study Of Atezolizumab Alone Or Combined With Immunomodulatory Drug And/or Daratumumab In Multiple Myeloma Patients

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. A Dose Finding And Safety Study Of CC-220, Alone And In Combination With An Anti-CD20 Monoclonal Antibody (MAb) In Subjects With Relapsed Or Refractory Lymphomas

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer